Vardenafil oral jellies as a potential approach for management of pediatric irritable bowel syndrome
Irritable bowel syndrome (IBS); a widespread disorder in gastrointestinal tract especially in children, burdens their healthcare systems and upsets families. Great attention was paid to understand the pathophysiological cause of disorder. However, developing a convenient treatment especially for chi...
Main Authors: | Eman Gomaa, Margrit M. Ayoub |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-09-01
|
Series: | Saudi Pharmaceutical Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S131901642100147X |
Similar Items
-
Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
by: Susanta Kumar Padhy, et al.
Published: (2015-10-01) -
Proinflammatory and anti-inflammatory cytokine profile in pediatric patients with irritable bowel syndrome
by: R. Vázquez-Frias, et al.
Published: (2015-01-01) -
Vardenafil Reduces Testicular Damage Following Ischemia/Reperfusion Injury in Rats
by: Bulent Erol, et al.
Published: (2009-07-01) -
Role of antispasmodics in the treatment of irritable bowel syndrome
by: V. N. Drozdov, et al.
Published: (2021-05-01) -
Irritable bowel syndrome
by: Vasile Valeriu LUPU, et al.
Published: (2016-03-01)